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INTRODUCTION 
 
Evidence-based medicine (EBM) is a scientific approach that supports 
the application of the best available research evidence to medical decision 
making. An understanding of EBM and how to implement it in practice is 
crucial for all professionals involved in the delivery of modern healthcare 
today. Guidelines are the most effective way of applying evidence into patient 
care. Potential increases in health costs and risks due to market-driven, 
uncontrolled use of novel clinical interventions also make guidelines 
increasingly important. 
Evidence-based recommendations are particularly important in areas of 
health care, where costs and mortality rates are very high. Burn care is one such 
area and according to a WHO estimate for our region the death and mortality 
rates are at least ten-fold higher than in Western Europe. High-income 
countries have made considerable progress in lowering rates of burn deaths 
through combination of proven prevention strategies and improvements in the 
care of burn victims. Most of these advances in prevention and care have been 
incompletely applied in low- and middle-income countries. Increased efforts to 
do so would likely lead to significant reductions in rates of burn-related death 
and disability. For these reasons we have identified burn care as a key topic in 
Hungary for guideline development with an evidence based methodological 
approach. 
Guidelines are systematically developed statements providing 
recommendations about the care of specific diseases. In addition, guidelines 
can play an important role in formulating health policy. CPGs ( Clinical 
Practice Guidelines) potentially improve the quality and processes of care by 
putting research findings into clinical practice, provided the recommendations 
are rigorously developed and based on the best available research evidence. 
Many organizations produce CPGs on similar topics worldwide, but their 
quality is highly variable.  
Good CPGs should be: outcome oriented; internally valid – i.e. based 
on high quality research evidence or formal consensus when evidence is 
conflicting or lacking; reliable – i.e. developed in an explicit, transparent and 
reproducible manner free from  commercial influence or bias; 
multidisciplinary; externally valid – i.e. clinically applicable; flexible – i.e. 
adaptable to various clinical circumstances and patient preferences; clear – i.e. 
specific and readily understood by users; regularly reviewed and updated; 
appropriately disseminated and implemented; cost-effective; and amenable to 
measurement of their impact in clinical practice. 
Guidelines can be adopted, developed de novo or adapted. Adoption of 
guidelines means that recommendations are used in the same format as issued 
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by the authority responsible for releasing the CPG. In de novo guideline 
development once the remit and clinical questions of the CPG are defined the 
critical steps in the process are how systematically the underlying research 
evidence is collected, selected, appraised and synthesized to give unbiased 
information which the CPG team can interpret further. This is probably the 
most time-consuming element of CPG development which needs special skills 
and training in systematic literature reviews and meta-analytic techniques. 
Often busy clinicians neither have the time, nor the necessary training to carry 
out such a thorough investigation. 
 Guideline adaptation, according to the definition of the ADAPTE 
Working Group, refers to the modification of a CPG produced for use in one 
cultural and organizational context to be applied in a different setting. 
Adaptation can be used as an alternative to de novo guideline development or 
for customizing an existing guideline to suit the local context. Unnecessary 
duplication could be avoided if high quality existing CPGs were adapted rather 
than developed de novo. This approach could be particularly beneficial for 
countries and organizations with limited budgets and experience or skills in 
evidence-based CPG development.  
 
AIMS OF THE STUDY 
    
Our main objectives were: 
- to identify and prioritize the key clinical questions in burn care to be 
addressed by evidence-based recommendations for national practice; 
- to systematically search for existing burn injury guideline 
recommendations for key questions, or in the lack of those, for the best 
available evidence on the topic;  
- to systematically assess the scope and the quality of evidence and that of 
CPGs;  
- to systematically synthesize the available evidence for burn care in primary 
studies and CPGs; and  
- to highlight potential shortcomings of current burn CPGs and gaps in our 
knowledge that may limit the effective delivery of care in practice. 
 
For our aims we addressed the following key questions: 
- Are prioritized topics and questions covered by existing guidelines for burn 
injury? 
- Do existing burn injury guidelines meet methodological standards? 
- What are the main shortcomings of existing burns injury guidelines and 
how we can explain those deficiencies? 
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- How does the methodological quality of guidelines for burn injury 
compare with those of other medical fields? 
- Is there sufficient evidence for formulating recommendations in burn 
injury guidelines? 
- What methods can be used to fill in evidence gaps when formulating 
recommendations? 
 
METHODS 
  
 For the adaptation of international CPGs of burn injury for local settings 
in Hungary, we followed the first 5 steps of the ADAPTE Working Group’s 
methodology. Steps 6 and 7 were beyond the scope of this study. We first 
established a multidisciplinary research team which included experts in CPG 
methodology, evidence based medicine, statistics, intensive care medicine, burn 
and plastic surgery. 
Definition and prioritization of key clinical topics and questions  
Key clinical topics for the CPG were primarily determined by mapping 
the usual care pathway of burn patients, and secondarily refined by collecting 
and comparing the scope of source CPGs. 
For prioritizing questions in each key CPG topic area we developed 
criteria which considered the potential impact of the intervention on important 
clinical, organizational or economic outcomes 
Searching for and selection of source CPGs 
 Literature search was carried out between January 1990 and December 
2008 systematically, screening MEDLINE and SCOPUS, the websites of 
several general medical burns-related journals and various burn associations, 
electronic databases of major CPG development and by reviewing the reference 
lists of review articles including CPGs. Searching in Medline was carried out 
using the terms of ("Burns"[MeSH] OR "Eye Burns"[MeSH] OR "Burns, 
Inhalation"[MeSH] OR "Burns, Electric"[MeSH] OR "Burns, 
Chemical"[MeSH]) AND ("CPG"[Publication Type] OR "CPGs"[MeSH] OR 
"Practice CPG"[Publication Type]). 
CPGs published in English, German or French were selected by two 
independent reviewers according to the following inclusion criteria: 1/ the 
publications were clinically relevant to burn injuries and provided 
recommendations for clinical practice; 2/ the type of publication fulfilled the 
definition of the Institute of Medicine for practice CPGs. 
Assessment of the clinical content of source CPGs  
 Because the guidelines varied in their scope, reviewers coded the CPGs 
according to whether they had recommendations for the 12 key clinical topics 
covered: i.e. fluid resuscitation, initial assessment and management, nutritional 
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support, referral, organization, delivery aspects of care, thromboprophylaxis, 
wound management, pain management, rehabilitation and reconstruction, 
electric injury, chemical burns, paediatric burn injuries and inhalation injuries. 
We defined recommendations as any statements that promote or advocate a 
particular course of action in clinical care. Two investigators working 
independently reviewed the guidelines for recommendations that covered the 
preset clinical topics. We resolved discrepancies through discussion within the 
study team. 
Appraisal of methodological quality  
We assessed the methodological quality of source CPGs by the AGREE 
Instrument in order to select those that are suitable for further analysis of their 
content and coherence before adaptation. Four assessors scored each CPG 
independently and reached consensus when necessary. 
The AGREE Instrument critically evaluates the quality of reporting and 
the methodological quality of CPGs according to 23 criteria, grouped into six 
domains: 1/ scope and purpose; 2/ stakeholder involvement; 3/ rigor of 
development; 4/ clarity and presentation; 5/ applicability; and 6/ editorial 
independence. Each of the 23 items in the checklist were  rated on a 4-point 
Likert scale ranging from 4 ‘Strongly agree’ to 1 ‘Strongly disagree’, with two 
mid points: 3 ‘Agree’ and 2 ‘Disagree’ The standardized percentage scores 
were calculated for each domain independently, as described in the manual of 
the AGREE Instrument 
We used kappa statistics as a measure of the agreement among 
reviewers. The kappa statistics for multiple raters was applied to each of the 23 
items of the AGREE Instrument. The MAGREE macro of the SAS system for 
Windows, that can handle the case of multiple raters, was used for calculations. 
 We also determined whether the CPG was evidence- or consensus-based 
(i.e. EB or CB). A CPG was classified as EB, when there was a documented 
and reproducible literature search methodology and/or some form of 
assessment of the quality of evidence while developing the CPG.  
  
 We compared the methodological quality of burn injury guidelines with 
that of other medical fields for two reasons: 
1. to see if the methodological scores found were specific to this particular   
field only or reflect a general quality of CPGs; 
2. to explore how consistent our guideline appraisal methodology is with 
published studies using the same critical appraisal technique. 
For this investigation we carried out a systematic search of the literature for any 
studies which used the AGREE Instrument for the critical appraisal of any 
guidelines. The following search terms were used to retrieve such studies and 
overviews: (“guidelines” AND “AGREE”). AGREE domain scores of the 
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retrieved studies were listed and results synthesized and compared to domain 
scores found for burn injury guidelines.  
Adaptation of recommendations  
 For efficient use of all published recommendations, in the fifth step of 
the framework, we have modified the ADAPTE process. The ADAPTE 
framework groups CPGs by similarity and uses separate tools for assessing 
guideline currency, consistency and applicability. As we have reviewed a large 
number of guidelines and wished to have each key question covered by a 
recommendation, we found it more practical to produce a comparative 
recommendation matrix for each key question with the relevant 
recommendations quoted from the actual source guidelines in chronological 
order, if available. 
Survey of the evidence based background of recommendations in burn injury 
 Because CB guidelines were more prevalent than expected, we were 
interested whether this could be explained by shortcomings of the burn 
literature. We performed a broad search in Medline between 1967 and 2010. 
The following search terms were used:  ("burns"[MeSH Terms] OR "Eye 
Burns"[MeSH] OR "Burns, Inhalation"[MeSH] OR "Burns, Electric"[MeSH] 
OR "Burns, Chemical"[MeSH]) NOT "sunburn"[MeSH Terms]) NOT burns 
[Author]. 
Methods for formulating recommendations when there is an evidence gap 
 Guideline adapting teams often face difficulties when no 
recommendations exist due to evidence gaps or conflicting expert opinions. 
Systematic reviewing techniques are used to fill in such evidence gaps. To pilot 
test this element of the guideline adaptation process, we chose another topical 
and as yet unresolved problem in dermatology, i.e. electrotherapy of melanoma 
metastases. We conducted a primary study and a systematic search of the 
medical literature to identify relevant studies on the effectiveness of bleomycin-
based electrotherapy on melanoma patients. The bibliographic search was 
performed from 1980 to January 2010 in the PubMed database, using the 
keywords [electrochemotherapy AND melanoma AND bleomycin].  
 
RESULTS 
 
Definition of key clinical topics and questions 
 Two main CPG areas (i.e., general management of burn injuries and 
special burn injuries) and 12 key topics with 55 key questions were defined. 
Main reasons for prioritization were if the intervention had a high impact on 
clinical outcomes (A1: 38 questions, 69%; A2: 23 questions, 42%; A3: 4 
questions, 7%; A4: 14 questions, 25%). Questions, related to economic (C: 9 
questions, 16%) and organizational outcomes (B1: 1 question, 2%; B2: 7 
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questions, 13%) were given gradually lower priority. Priority scores were given 
from 1 (most important) to 4 (least important).    
Search results, selection of guidelines 
 We screened 519 citations identified through computerized database 
searches. An additional 27 citations had been identified through hand searching 
in reference lists of papers, and web site searches of CPG resources. After 
screening for relevance and other preset inclusion and exclusion criteria, we 
retained 24 CPGs for further evaluation and critical appraisal. Selected CPGs 
were of two types: 1/ specifically oriented to burns, and 2/ other clinical CPGs 
in which certain chapters dealt with the management of burn injury. 
Main characteristics of and clinical topics covered in selected guidelines 
 Of the 24 CPGs, 42% (n=10) were evidence-based (EB), and the rest 
consensus-based (CB). For paediatric burn injuries and pain management we 
found only CB CPGs, while for thromboprophylaxis and nutritional support the 
majority of CPGs were EB. Sixty percent of CPGs for electric and inhalation 
injuries were also EB. A number of CPGs addressed the topics which are most 
important in terms of patients’ outcomes in the first 24-48 hours of burn injury. 
Due to the nature of burn disease most CPGs provided recommendations for 
initial assessment (n=15, 63%) and immediate fluid resuscitation (n=8, 29%) 
that are crucial for patient survival, but nearly two thirds of these were CB. In 
terms of outcomes it is essential that after initial assessment patients are triaged 
for referral to a burn centre. Six CPGs (25%) made recommendations on 
referral criteria, and other important organizational aspects of care, and only 
one third of these were EB. 
 
Evaluation of the quality and coherence of source CPGs 
 
Scope and purpose 
 Most CPGs performed well in this domain with a mean score of 74%, 
with only five CPGs (21%) scoring less than 60%. There was no difference 
between the mean scores of EB versus CB CPGs in this domain. 
Stakeholder involvement 
 The mean score for this domain was 35%, with only 2 CPGs (8%) 
scoring slightly above 60%. Only 5 CPGs (21%) included individuals from all 
relevant professional groups in the development stage, and none was piloted 
among end-users. The average scores of EB and CB CPGs did not differ. 
Rigor of development 
 In this domain the mean score was 38%, with 71% of CPGs scoring 
<60%. Only 5 CPGs (21%) described systematic methods for searching and 
selecting the evidence, 8 CPGs (33%) considered health benefits, side effects 
and risks when formulating the recommendations, and 7 CPGs (29%) described 
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the methods used to formulate the recommendations. Seven CPGs (29%) were 
externally reviewed prior to publication. Eight CPGs (33%) provided any 
procedure for future. The mean score in this domain was much lower in CB 
(22%) than in EB CPGs (61%).  
Clarity and presentation 
 The mean score was 79%, and only two CPGs (8%) scored <60% for 
this domain. Three CPGs (13%) included tools for application. The average 
scores of EB and CB CPGs did not differ. 
Applicability 
 In this domain the mean score was 21% with only one CPG scoring 
>60%. Three CPGs provided review criteria for monitoring purposes, and also 
3 discussed potential organizational barriers. No CPG discussed cost 
implications. Consensus-based CPGs scored somewhat lower (18%) than EB 
ones (27%). 
Editorial independence 
 The score in this domain was the lowest of all, with a mean of 17%. 
Four CPGs (17%) scored >60%. Potential conflicts of interests of CPG 
developers were recorded only in 3 CPGs (12%). Evidence-based CPGs scored 
much better but still only about one third of them reported these issues as 
compared to 8% of CB CPGs. 
Overall recommendations 
 After assessing the quality of all CPGs reviewers recommended for 
adaptation those that were considered to influence outcomes in some form and 
that demonstrated acceptable quality on the AGREE instrument. In total, we 
recommended 16 (67%) CPGs for adaptation of which 9 (56%) were EB, and 7 
(44%) CB. Two EB CPGs (8%) were strongly recommended and 14 (58%) 
with provisos or alterations. 
 Agreement among Reviewers 
 The kappa values indicate that overall agreement was fair to moderate 
for 61% of the items and was substantial to excellent for 39% of the items. In 
the final rating where there were some disagreements assessors based their 
scores on consensus.  
Comparison of the methodological quality of burn guidelines with guidelines 
in other medical fields 
 In many medical fields altogether 1338 CPGs were investigated with the 
AGREE instrument, including results of our own systematic review of 712 
CPGs  along with a more recent systematic review of 626 CPGs published 
between 2003 and 2008 . This overview revealed that in most guidelines the 
scope and purpose of recommendations are clearly defined and guidance is 
given in a clear format. There are significant shortcomings, however, in the 
multidisciplinary composition of guideline teams and involvement of patients 
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in formulating recommendations. The scores in these critical assessments were 
also low for the rigour (or reporting) of an evidence-based CPG methodology. 
Guidelines often fail the criteria of editorial independence, i.e. reporting on 
funding and potential conflicts of interest. Furthermore, all reviews found that 
most recommendations lack external validity, i.e. applicability in practice. The 
average domain scores in these reviews are very similar to what we have found 
in burns CPGs.  
Modification of the ADAPTE process  
 For a more effective guideline adaptation and for the efficient use of all 
published recommendations we modified the fifth step of the ADAPTE 
framework and developed an algorithm. This modification enables guideline 
teams to address all tailored a priori questions, and to objectively compare the 
underlying evidence with final recommendations in various guidelines. 
Literature review for high quality evidences in burn care 
 By searching MEDLINE for primary evidence in burn literature, a total 
number of 41.502 publications were evaluated, of which 10.830 (26%) could be 
classified according to the evidence hierarchy. Of these only 19 (0.04%) were 
meta-analyses, 606 (1.4%) randomized controlled trials, 904 (2.2%) clinical 
trials, 2745 (6.6%) comparative studies and 6556 (15 %) case series and case 
reports. 
Formulating recommendations when there is an evidence gap 
 We performed a local primary study and compared our own findings to 
a systematic literature search from 1980 to January 2010 in the PubMed 
database. We retrieved 27 papers of which, after checking titles and abstracts, 
11 were identified as being relevant for inclusion. Due to the low sample size in 
each study, we did not carry out a meta-analysis, even though objective 
response rates to treatment showed fairly homogeneous results.  
 
DISCUSSION 
 
 Before adapting international CPGs to local practice the following 
questions need to be addressed: 1/ Are international guidelines of appropriate 
quality available? 2/ Are published recommendations based on the best 
available evidence, or in the lack of it on expert consensus conceived in a 
transparent and explicit process? 3/ Are recommendations transferable to our 
local settings?  Our guideline adaptation study on burn care investigated all 
these issues and resulted in a pilot tested framework of methods that can be 
successfully used by guideline teams in various medical disciplines. 
 The assessment of guideline attributes by using the AGREE scores 
helped in deciding which guidelines could be trusted and used to base our local 
recommendations upon. 
 9 
 In general, as EB CPG methods have been published in the examined 
last 5 years or so, we expected some improvement of methodological quality of 
CPGs over time. In fact, neither the number of EB vs CB CPGs, nor the actual 
AGREE domain scores showed any tendency of improvement 
 Our study demonstrates that the majority of burns CPGs defined their 
scope and purpose reasonably well and presented their recommendations 
clearly. In this respect we found no difference between EB and CB CPGs. 
Equally, no difference could be seen between CB and EB CPGs in terms of 
multidisciplinarity. Nevertheless, both types of CPGs often failed to involve 
related disciplines in the development process, even though a European survey 
has shown that in intensive care practice mostly plastic and trauma surgeons 
and anaesthetists are responsible for the management of burn injuries. 
 The adequacy of CPGs for adaptation is best reflected by the rigor of 
development and clinical applicability of the recommendations. In both 
domains burns CPGs achieved rather low scores (i.e., 38% and 21%, 
respectively). The low scores in the former are explained by the fact that most 
of the reviewed CPGs referred to some underlying literature, but many did not 
report the methodology of literature retrieval and selection or how 
recommendations were finally arrived at. One may argue that the large 
difference we found between the scores of EB and CB CPGs in the “rigor of 
development” domain (i.e., 61% versus 22%) is due to the fact that the AGREE 
Instrument is mostly applicable to evidence-based CPGs. In our assessment and 
according to the AGREE criteria, CB CPGs are also considered valid and may 
receive high scores, provided it is made explicit and transparent  that authors 
searched for and appraised the literature, but due to the lack of suitable 
evidence a multidisciplinary expert team had to conceive its recommendations 
in a formal consensus process.   
 For CPG adapters, thorough documentation and reporting of such 
processes in source CPGs is particularly important as consensus is often 
influenced by local value judgements related to societal, cultural, organizational 
and economic aspects of care which are not directly transferable from one 
setting to another.     
 CPG validity depends not only on the rigor of its development but also 
on the quality of the underlying evidence base. Our literature review for high 
quality evidences confirmed the results of a recent study that evaluated the 
quantity and quality of research evidence in peer-reviewed burn care journals. 
We therefore conclude that burn care literature suffers from a shortage of high-
quality evidence which explains why consensus based guidelines are in the 
majority. 
There are many explanations for the lack of appropriately designed and 
executed trials in burn literature; patient population may grossly differ by age, 
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comorbidities, the extent of the injury, etc. Therefore recruiting the number of 
treated patients needed for a randomised controlled trial either takes a long 
period of time or needs a wide-scale international collaboration amongst burn 
centres. Because of the irreversibility of surgical treatments, randomisation can 
also cause ethical problems for surgeons when utilising new treatments which 
they have less knowledge of and/or trust in their efficacy. For the same reasons 
it is difficult to get patients’ consent for taking part in a randomised trial. These 
problems do not only affect burn surgery, but in general the whole surgical 
field. 
 Nevertheless, well conducted CB guidelines proved to be valuable, 
especially in a field, where we are lacking a solid underlying evidence base. 
Good quality consensus based guidelines, which were developed with a 
rigorous methodology and by formal consensus techniques are worthy for 
adaptation. 
 Our study demonstrated that especially in areas where the evidence base 
is not particularly strong, guideline adaptation could be made more effective 
and explicit by following the modified ADAPTE process. The biggest 
advantage of this modification is that it maximizes the potential to address all 
tailored a priori questions and facilitates the objective appraisal, synthesis and 
comparison of the validity and consistency of the underlying evidence across 
various guidelines. This modified framework also assists in grading or re-
grading the adapted recommendations. The strength of this process lies in its 
transparency and reproducibility. 
 Systematic overviews coupled with evidence from appropriately 
designed local studies can assist in making recommendations that can be 
applied to national practice even in areas where there is no international 
consensus or guidance to inform the guideline adaptation team. 
 Electrochemotherapy, which is a novel method in the treatment of the 
cutaneous metastases of malignant melanoma, was chosen as an example where 
clear recommendations for practice are still lacking and there are conflicting 
views on its effectiveness. Our example also demonstrates how to translate new 
knowledge into clinical practice and health decision making, which is one of 
the principal aims of EBM. Such systematic reviews compared to local 
experience on limited number of cases also help guideline teams to make 
informed and graded recommendations in a more objective and evidence-based 
fashion.   
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SUMMARY 
 
• We have developed and pilot tested a contemporary, evidence-based guideline 
adaptation framework that meets international methodological standards and 
can be universally used in any medical field when international CPGs are 
adapted to local use in Hungary. 
• We have developed prioritization criteria for defining key clinical topics and 
questions for guidelines. These criteria are primarily based on patient relevant 
clinical, organisational and economic outcome considerations, and help 
guideline teams in addressing high priority topics in guidelines with more 
rigorous and transparent evidence-based methodologies. 
• We have modified the ADAPTE process to make guideline adaptation more 
effective and explicit. The modification maximizes the potential to address all 
tailored key questions and enables the objective comparison and efficient use 
of all published recommendations. It also provides a tool for a more 
transparent (re)grading of recommendations based on the quality of evidence 
and other pragmatic, value-based considerations. 
• We have proposed and pilot tested systematic reviewing techniques coupled 
with local primary studies to help formulating recommendations when 
evidence is lacking or controversial. 
• We have mapped that all high priority burn injury topics were covered by at 
least one CPG, but no single CPG addressed all areas. This highlights the need 
that guideline adaptation must be a systematic process and should not simply 
rely on adoption of any one preselected international CPG. 
• We have shown that the majority of burn injury guidelines are consensus 
based and a large proportion of recommendations are based on lower levels of 
evidence or expert opinion. As an explanation we have found that burn care 
literature suffers from a shortage of high-quality evidence which is partly due 
to organisational and ethical barriers of performing large-scale randomised 
controlled trials.  
• Whilst existing international CPGs for the management of burn injury may 
accurately reflect agreed clinical practice, most performed poorly when 
evaluated for methodological quality by the AGREE Instrument. 
• The methodological shortcomings of burn injury CPGs are very similar to 
those in other medical fields. 
• Critical appraisal of international burns CPGs revealed that the majority 
defined their scope and purpose well, but there were serious shortcomings in 
involving all relevant stakeholders in the guideline development process and 
in the rigour and editorial independence of the development of 
recommendations. Burn injury CPGs also failed the majority of the clinical 
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applicability criteria. These methodological shortcomings raise concerns 
about both the internal and the external validity of recommendations and 
therefore guideline adaptation teams must investigate the evidence or 
reasoning behind key recommendations before formulating and releasing local 
guidelines. 
 
In conclusions, we make the following recommendations for the future: 
 
• To improve the quality and validity of current guidelines systematic and 
explicit methods, based on the state-of-the art of guideline development and 
adaptation, are needed in burn care and any other medical fields. 
•  In Hungary guideline adaptation is a more pragmatic and cost-efficient 
approach and should adhere to a standardized framework, such as the one 
pilot tested in this study. 
• All external CPGs should be critically evaluated for methodology and content 
before recommendations are adopted/adapted and endorsed for use in clinical 
practice.  
• Guideline adaptation needs special skills and basic knowledge in evidence-
based medicine and critical appraisal techniques, therefore training of 
guideline adapting teams should precede any such endeavours.   
• Guideline adaptation should involve a close collaboration between all relevant 
stakeholders caring for the condition targeted by the recommendations.  
• Guideline teams must disclose any potential conflicts of interest that might 
bias their judgment while formulating recommendations. 
• Beyond the evidence the guideline adaptation team should consider the 
practical aspects and applicability of international recommendations, and 
diversions form the evidence or any other reasoning behind local 
recommendations should be documented explicitly and transparently. 
• A standardised grading/re-grading system should be developed for adapting 
international recommendations in Hungary.  
Future CPG efforts addressing these issues would add substantially to the 
improved management of burn injury and any other medical conditions in 
Hungary. 
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